, Volume 107, Issue 4, pp 489–496

Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-d-aspartate receptor complex

  • Phil Skolnick
  • Rachel Miller
  • Andrew Young
  • Kathleen Boje
  • Ramon Trullas
Original Investigations


Functional antagonists at the N-methyl-d-aspartate (NMDA) receptor complex produce anti-depressant-like actions in preclinical models. Thus, an injection of a glycine partial agonist (1-aminocyclopropanecarboxylic acid; ACPC), a competitive NMDA antagonist (2-amino-7-phosphonoheptanoic acid; AP-7) or a use-dependent cation channel blocker (MK-801) reduced immobility in the forced swim test (FST) with efficacies comparable to imipramine (Trullas and Skolnick 1990). Seven daily injections of ACPC (200–400 mg/kg) abolished the effects of both this compound (200–1200 mg/kg) and AP-7 (200–300 mg/kg) in the FST. The loss in effectiveness of ACPC required 7 days of treatment to become fully manifest, and was reversed by discontinuing treatment. Other agents active in the FST (e.g. MK-801, imipramine, and nifedipine) were unaffected by this regimen. Moreover, ACPC and AP-7 remained active in the FST following repeated injections of MK-801, AP-7, or imipramine. Chronic treatment with ACPC did not affect its actions in the elevated plus-maze, but significantly attenuated the convulsant and lethal effects of NMDA (125 mg/kg). Tissue levels of ACPC indicate the modified behavioral responses produced by chronic treatment are not attributable to pharmacokinetic factors. These findings suggest repeated administration of ACPC may effect an “uncoupling” of NMDA and glycine receptors, resulting in an apparent desensitization of the behavioral actions of substances acting at these sites.

Key words

Glycine 1-Aminocyclopropanecarboxylic acid MK-801 N-methyl-d-aspartate Forced swim test 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bennett D, Amrick C (1986) 2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam, Life Sci 39:2455–2461Google Scholar
  2. Benveniste M, Clements J, Vyklicky L, Mayer M (1990) A kinetic analysis of the modulation of N-methyl-d-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J Physiol (London) 428:333–357Google Scholar
  3. Boast C, Pastor G, Gerhardt S, Hall N, Liebman J (1988) Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-d-aspartate receptor antagonist. J Pharmacol Exp Ther 247:556–561Google Scholar
  4. Collingridge G, Kehl S, McLennan H (1983) Excitatory amino acid in synaptic transmission in the Schaffer collateral commissural pathway of the rat hippocampus. J Physiol 334:33–46Google Scholar
  5. Compton R, Hood W, Monahan J (1991) Evidence for a functional coupling of the NMDA and glycine recognition sites in synaptic plasma membranes. Eur J Pharmacol 188:63–70Google Scholar
  6. Desan P, Silbert L, Maier S (1988) Long-term effects of inescapable stress on daily running activity and antagonism by desipramine, Pharmacol Biochem Behav 30:21–29Google Scholar
  7. Evans R, Francis A, Jones A, Smith D, Watkins J (1982) The effects of a series of ω-phosphonic-α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations. Br J Pharmacol 75:65–75Google Scholar
  8. Evoniuk G, Hertzman R, Skolnick P (1991) A rapid method for detecting phencyclidine-like dissociative anesthetics in mice. Psychopharmacology 105:125–128Google Scholar
  9. Harris E, Ganong A, Cotman C (1984) Long term potentiation in the hippocampus involves activation in N-methyl-d-aspartate receptors. Brain Res 323:132–137Google Scholar
  10. Heninger G, Charney D (1987) Mechanism of action of antidepressant treatments: implications for the etiology and treatment of depressived disorders. In: Meltzer H (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 535–544Google Scholar
  11. Huettner J, Bean B (1988) Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85:1307–1311Google Scholar
  12. Johnson K, Jones S (1990) Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu Rev Pharmacol Toxicol 30:707–750Google Scholar
  13. Johnson K, Snell L, Sacaan L, Jones S (1989) Pharmacological regulation of the phencyclidine-binding site associated with the N-methyl-d-aspartate receptor-operated ion channel. Drug Dev Res 17:281–297Google Scholar
  14. Kemp J, Priestley T (1991) Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-d-aspartate receptor agonist responses in rat cultured cortical neurons. Mol Pharmacol 39:666–670Google Scholar
  15. Lehmann J, Schneider J, McPherson S, Murphy D, Bernard P, Tsai C, Bennett D, Pastor G, Steel D, Boehm C, Cheney D, Liebman J, Williams M, Wood P (1987) CPP, a selective N-methyl-d-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther 240:737–746Google Scholar
  16. Leshner A, Remler A, Bigeon A, Samuel D (1979) Effects of desmethylimipramine on learned helplessness. Psychopharmacology 66:207–208Google Scholar
  17. Lister R (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185Google Scholar
  18. Marvizon J, Lewin A, Skolnick P (1989) 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-d-aspartate receptor complex. J Neurochem 52:992–994Google Scholar
  19. Monaghan D, Holets V, Toy D, Cotman C (1983) Anatomical distribution of four anatomically [3H]glutamate binding sites. Nature 306:176–179Google Scholar
  20. Monaghan D, Yao D, Olverman H, Watkins J, Cotman C (1984) Autoradiography ofd-2-[3H]amino-5-phosphonopentanoate binding sites in rat brain. Neurosci Lett 52:253–258Google Scholar
  21. Monaghan D, Olverman H, Nguyen L, Watkins J, Cotman C (1988) Two classes of N-methyl-d-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 85:9836–9840Google Scholar
  22. Oswald I, Brezinova V, Dunleavy D (1972) On the slowness of action of tricyclic antidepressant drugs. Br J Psychiatry 120:673–677Google Scholar
  23. Paul I, Trullas R, Skolnick P, Nowak G (1992) Downregulation of cortical β-adrenoceptors by chronic treatment with functional antagonists of the NMDA receptor complex. Psychopharmacology 106:285–287Google Scholar
  24. Petty F, Sherman A (1980) Reversal of learned helplessness by imipramine, Commun Psychopharmacol 3:371–373Google Scholar
  25. Porsolt R (1981) Behavioral despair. In: Enna S, Malick J, Richelson E (eds) Antidepressants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 121–139Google Scholar
  26. Porsolt R, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336Google Scholar
  27. Robinson M, Coyle J (1987) Glutamate and related excitatory amino neurotransmitters: from basic science to clinical application. FASEB J 1:446–455Google Scholar
  28. Rogawski M, Thurkauf A, Rice K, Jacobsen A, Ffrench-Mullen J (1988) Anticonvulsant activity of phencyclidine analogs: structural modifications resulting in enhanced seizure protection relative to motor side effects. In: Cavalheiro EA, Lehmann J, Turski L (eds) Frontiers in excitatory amino acid research. Liss, New York, pp 227–230Google Scholar
  29. Shanks N, Anisman H (1989) Strain-specific effects of antidepressants on escape deficits induced by inescapable shock, Psychopharmacology 99:122–128Google Scholar
  30. Shors T, Seib T, Levine S, Thompson R (1989) Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science 244:224–226Google Scholar
  31. Sills M, Fagg G, Pozza M, Angst C, Brundish D, Hurt S, Wilusz E, Williams M (1991) [3H]CGP 39653: a new N-methyl-d-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Eur J Pharmacol 192:19–24Google Scholar
  32. Skolnick P, Marvizon J, Jackson B, Monn J, Rice K, Lewin A (1989) Blockade of N-methyl-d-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci 45:1647–1655Google Scholar
  33. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370Google Scholar
  34. Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1–10Google Scholar
  35. Trullas R, Jackson B, Skolnick P (1989) 1-Aminocyclopropanecarboxylic acid, a ligand of the strychnine-insensitive glycine binding site exhibits anxiolytic properties. Pharmacol Biochem Behav 34:313–316Google Scholar
  36. Trullas R, Folio T, Young A, Miller R, Boje K, Skolnick P (1991) 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur J Pharmacol (in press)Google Scholar
  37. Watson G, Lanthorn T (1990) Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-d-aspartate receptor associated glycine site. Neuropharmacology 29:727–730Google Scholar
  38. Winslow J, Insel T, Trullas R, Skolnick P (1990) Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex. Eur J Pharmacol 190:11–22Google Scholar
  39. Wong E, Kemp J, Priestley T, Knight A, Woodruff G, Iversen L (1986) The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc Natl Acad Sci USA 83:7104–7108Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Phil Skolnick
    • 1
  • Rachel Miller
    • 1
  • Andrew Young
    • 1
  • Kathleen Boje
    • 1
  • Ramon Trullas
    • 1
  1. 1.Laboratory of Neuroscience, NIDDKNational Institutes of HealthBethesdaUSA

Personalised recommendations